v3.26.1
Condensed Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Current assets    
Cash and cash equivalents $ 45,252 $ 40,476
Marketable securities 95,932 118,785
Accounts receivable, net 15,712 15,053
Inventory 6,902 7,288
Contract costs, current 2,231 2,210
Prepaid expenses and other current assets 2,882 2,906
Total current assets 168,911 186,718
Property and equipment, net 1,926 2,030
Operating lease right-of-use assets 2,041 2,296
Contract costs, long-term 1,742 1,847
Other non-current assets 3,458 2,912
Total assets 178,078 195,803
Current liabilities    
Accounts payable 1,981 2,838
Accrued liabilities 12,561 14,328
Contract liabilities, current 88 101
Operating lease liability, current 1,141 1,105
Other current liabilities 413 818
Total current liabilities 16,184 19,190
Long-term liabilities    
Notes payable, long-term 19,917 19,811
Other liabilities, long-term 106 106
Operating lease liability, long-term 1,058 1,360
Total long-term liabilities 21,081 21,277
Total liabilities 37,265 40,467
Commitments and contingencies (Note 7)
Stockholders' equity    
Preferred stock, $0.001 par value; Authorized shares: 10,000,000 March 31, 2026 and December 31, 2025 respectively Issued and outstanding shares: none as of March 31, 2026 and December 31, 2025 respectively
Common stock, $0.001 par value; Authorized shares: 500,000,000 March 31, 2026 and December 31, 2025, respectively Issued and outstanding shares: 37,859,680 and 37,485,124 as of March 31, 2026 and December 31, 2025, respectively 38 38
Additional paid-in capital 380,850 375,495
Accumulated other comprehensive income 18 159
Accumulated deficit (240,093) (220,356)
Total stockholders' equity 140,813 155,336
Total liabilities and stockholders' equity $ 178,078 $ 195,803